Table 1.
n = patients | 112 | |||
Age, medium (IQR), years | 64.5 (60–68) | |||
PSA, medium (IQR), ng/ml | 9.3 (6.6–12.25) | |||
n = lesions | 170 | |||
Lesion zones, n (%) | ||||
Peripheral zone (PZ) | 124 (72.94%) | |||
Transitional zone (TZ)/central zone (cz) | 46 (27.06%) | |||
Gleason grade group, n (%) | ||||
1 (Gleason score 3 + 3) | 28 (16.47%) | |||
2(Gleason score 3 + 4) | 77 (45.29%) | |||
3 (Gleason score 4 + 3) | 31 (18.23%) | |||
4 (Gleason score 4 + 4.3 + 5.5 + 3 | 17 (10%) | |||
5 (Gleason score 4 + 5.5 + 4) | 17 (10%) | |||
n = 2D axial images, n (%) | SA = 1261 | SB = 1253 | ||
Atrain = 875 (69.4%) | Atest = 386 (30.6%) | Btrain = 870 (69.4) | Btest = 383 (30.6%) | |
non-csPCa(GGG = 1, benign) | 594 (47.1%) | 265 (21.0%) | 583 (46.5%) | 262 (20.9%) |
csPCa (GGG ≤ 1) | 281(22.3%) | 121 (9.6%) | 287 (22.9%) | 121 (9.7%) |
Axial images refer to each 2D axial slice of the whole prostate volume. Each image is considered as positive if a clinically significant prostate cancer (csPCa) lesion exists on the image or is considered as negative
IQR inter-quantile range